Skip to content
Disclosery

EXANE DERIVATIVES: K position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on K, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 14,419 K shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 14,419 shares
    Change vs previous 13F -2,028 shares

    0.59% of the 13F portfolio, value $1,028,526.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 16,447 shares
    Change vs previous 13F +2,816 shares

    0.3% of the 13F portfolio, value $1,060,674.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 13,631 shares
    Change vs previous 13F +820 shares

    0.21% of the 13F portfolio, value $878,137.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 12,811 shares
    Change vs previous 13F +3,012 shares

    0.2% of the 13F portfolio, value $818,911.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 9,799 shares
    Change vs previous 13F +398 shares

    0.15% of the 13F portfolio, value $618,919.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 9,401 shares
    Change vs previous 13F +9,329 shares

    0.18% of the 13F portfolio, value $595,111.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 72 shares
    Change vs previous 13F 0 shares

    <0.01% of the 13F portfolio, value $4,481.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 72 shares
    Change vs previous 13F not available

    <0.01% of the 13F portfolio, value $4,651.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).